Retatrutide (5mg)

Retatrutide is a medication currently under investigation for the treatment of obesity and type 2 diabetes. It is a triple receptor agonist that activates the glucagon, gastric inhibitory polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors. 

Benefits of Retatrutide: 

• Significant weight loss:
  Studies have shown that retatrutide can lead to significant weight loss, with participants losing an average of 12-17% of their body weight over 48 weeks. 
  
  Improved glycemic control:
  
• Retatrutide can help improve blood sugar control in people with type 2 diabetes. 
  
  Reduced liver fat:
  
• Studies have indicated that retatrutide can reduce liver fat, which is a risk factor for non-alcoholic fatty liver disease (NAFLD). 
  
  Decreased hunger and satiety:
  
• Retatrutide works by stimulating the GIP and GLP-1 receptors, which helps to regulate appetite and make individuals feel fuller for longer. 
  
  Improved cardiovascular health:
  
• Studies suggest that retatrutide may improve cardiovascular health by lowering blood pressure and reducing cholesterol levels. 
  
  Well-tolerated:
  
• Retatrutide is generally well-tolerated, with the most common side effects being gastrointestinal issues such as nausea, vomiting, and diarrhea. 
  
  Other Potential Benefits: 
• Retatrutide may have potential benefits for treating metabolic syndrome and improving metabolic health. 

• It may also be an option for people who have not been successful with other weight loss treatments. 

(Lyophilized Powder)